Dr Lakis Liloglou B.Sc.(hons), Ph.D.
Senior Lecturer in molecular oncology Molecular & Clinical Cancer Medicine
- +44 (0)151 794 8904 / +44 (0)151 794 8920 / +44 (0)151 794 8958 / +44 (0)151 794 9121
- Work email T.Liloglou@liverpool.ac.uk
Research
Research Interest 1
Molecular biology of respirstory tract cancers. Epigenetic analysis and Biomarker development for early detection, patient statification and therapeutic monitoring.
Genomic Instability and transposable elements.
Research Group Membership
Research Grants
Bench fee support to student Ahmed al Khafaji
REPUBLIC OF IRAQ MINISTRY OF EDUCATION
September 2012 - August 2014
Novel epigenetic biomarkers in the diagnosis of minimal residual disease in head and neck cancer.
CANCER RESEARCH UK (UK)
September 2007 - April 2009
Validation of a DNA methylation signature in plasma as an early lung cancer diagnostic tool
ROY CASTLE LUNG CANCER FOUNDATION (UK)
September 2013 - August 2016
Liverpool Lung Project - Genetic Instability.
ROY CASTLE LUNG CANCER FOUNDATION (UK)
January 2004 - December 2004
Methylation - an early lung cancer diagnostic.
ROY CASTLE LUNG CANCER FOUNDATION (UK)
October 2002 - September 2005
Validation of DNA methylation biomarkers for early lung cancer diagnosis in case-control populations and in a primary care high risk cohort population
CANCER RESEARCH UK (UK)
October 2010 - September 2012
miRNA deregulation in respiratory cancers
ROYAL SOCIETY (CHARITABLE)
June 2011 - May 2013
Long non-coding RNA biomarkers for early detection of lung cancer
ROY CASTLE LUNG CANCER FOUNDATION (UK)
November 2014 - December 2015
Roy Castle Lung Cancer Research Programme
ROY CASTLE LUNG CANCER FOUNDATION (UK)
January 2006 - March 2018
MicroRNA biomarkers in surrogate airway tissues for early lung cancer detection
ROY CASTLE LUNG CANCER FOUNDATION (UK)
July 2012 - February 2013
Detection of oral squamous cell carcinoma using epigenetic markers in saliva-derived DNA
BRITISH ASSOCIATION OF ORAL MAXILLOFACIAL SURGEONS (UK)
April 2010 - March 2012
The Liverpool Lung Project - Research Fellowship
ROY CASTLE LUNG CANCER FOUNDATION (UK)
January 2008 - December 2010
Identification of early lung cancer genes using an in vitro carcinogenesis model in organotypic bronchial epithelial cell culture system.
DEPARTMENT OF TRADE AND INDUSTRY (UK)
May 2004 - November 2005
Bench fee support for PhD student
NIGER DELTA DEVELOPMENT COMMISSION (NDDC)(NIGERIA)
October 2013 - September 2017
Bench fees to support PhD student
REPUBLIC OF IRAQ MINISTRY OF EDUCATION
December 2013 - November 2016
Research Collaborations
Dr Janet Risk
Internal
Head and neck cancer
Dr Aristides Eliopoulos
External: University of Crete
Investigation of the TPL-2 kinase status in lung cancer and contribution to inflammation - realted carcinogenesis.
Dr Alex Santori
External: Applied Biosystems
Development of new quantitative method for DNA methylation detection
Andreas Weinhäusel
External: Austrian Research Centers GmbH - ARC
DNA methylation targets for lung cancer diagnosis
Volker Liebenberg
External: Epigenomics, AG
Epigenetic biomarkers for lung cancer detection
Dr Mark Boyd
Internal
MDM2 impact on genome methylation maintenance
Dr Neil Gibson
External: AstraZeneca Pharmceuticals
DNA methylation analysis for therapeutic stratification (information can not disclosed publically)
Dr Richard Shaw
Internal
DNA methylation markers for the diagnosis/prognosis of head and neck tumours
Dr Vassilis Gorgoulis
External: University of Athens
There is an on-going collaboration between the two labs for many years on genomic instability, DNA damage and lung cancer development